Chinese Billionaires Turn to U.S. Surrogates, Challenging Birthright Citizenship Rules

(UNITED STATES) — Wealthy Chinese intended parents are using U.S. surrogacy services on a scale that is drawing fresh scrutiny over birthright citizenship, family law and possible criminal abuse, with Chinese billionaires including Xu Bo at the center of the debate.

The arrangements have brought renewed attention to a little-tested intersection of the 14th Amendment, cross-border reproductive business and the legal status of children born through gestational surrogacy. Critics have raised concerns about exploitation of surrogates, the creation of very large families and whether American law leaves gaps that foreign clients can use.

Xu Bo, a Chinese video-game billionaire from Duoyi Network, has commissioned “only a little over 100” U.S. surrogacy births, including 12 confirmed American children he has mostly never met. His former girlfriend, Tang Jing, claimed he fathered up to 300 children across countries, though his company disputed that figure.

Those cases have turned an industry story into a national one. U.S. officials have interviewed surrogates tied to Chinese intended parents, lawmakers have proposed restrictions, and courts are weighing disputes that test how far intended parentage rights extend when children are born in the United States.

A 2023 ruling in Los Angeles became one of the clearest flashpoints. Judge Amy Pellman denied Xu parentage rights over 4 U.S.-born surrogacy children he had not met, leaving the children in legal limbo and marking a rare rebuke in surrogacy approvals.

Another case in Nevada has also drawn attention. A surrogate sued an unnamed California couple, alleging deception after she discovered she had carried their 26th child, and the FBI is investigating potential baby-selling at scale.

Wang Huiwu, another executive, arranged surrogacies for 10 daughters to build influence, adding to broader worries among critics that some wealthy clients are using the U.S. system not only to expand families but to secure American citizenship for children in unusually large numbers.

Birthright citizenship remains central to the issue. Children born in the United States through gestational surrogacy, where a surrogate carries an embryo from intended parents’ gametes, automatically gain citizenship under the 14th Amendment regardless of parental status under current constitutional practice.

That legal framework has made the United States attractive to foreign clients, especially in states with permissive surrogacy rules and established court procedures for intended parents. In this market, American citizenship at birth is widely seen as one of the main draws.

Gestational surrogacy also creates harder legal questions about who counts as a parent for citizenship-related claims. President Trump’s 2025 executive order sought to deny citizenship if the “immediate female biological progenitor” was unlawfully or temporarily present and the father lacked U.S. citizenship or permanent residency, while courts define the surrogate as not the legal mother.

Federal courts blocked that order in Barbara v. Trump and State of Washington v. Trump. The legal challenge drew 22 state attorneys general and advocacy groups, and Supreme Court challenges are expected early 2026.

Legal experts have said any durable nationwide change would require a constitutional amendment rather than executive action alone. For now, citizenship for children born in the United States through gestational surrogacy remains intact.

The business structure behind these cases helps explain how such arrangements can happen at scale. Costs per child can reach $200,000, limiting the practice to extremely wealthy intended parents and making it part of a high-end international market.

That market relies on a web of fertility clinics, surrogacy agencies, lawyers, coordinators and court proceedings. Together they can handle embryo creation, matching, pregnancy management and parentage orders, often across state lines and national borders.

Some intended parents reportedly complete these arrangements with little or no travel to the United States. That has raised questions about how much direct contact they have with the children, the surrogates and the court systems that approve the parentage arrangements.

Commercial surrogacy is banned in China, and that restriction helped push demand toward the United States. Chinese clients became a prominent part of international surrogacy demand during the years from 2014 to 2019, when cross-border business grew strongly before the pandemic.

American states with lighter regulation became especially attractive in that period. Surrogacy firms such as Ember Fertility have continued to market the United States as offering stable legal outcomes for intended parents, even as the political debate has sharpened.

Federal investigators are now looking more closely at that world. The FBI and the Department of Homeland Security have interviewed surrogates tied to Chinese intended parents, though officials have not disclosed the focus of those interviews.

The Nevada lawsuit involving the California couple has become one of the most closely watched matters because it combines allegations of deception, an unusually large number of children and possible criminal conduct. A judge is expected to rule on the couple’s rights involving their 26 children.

Congress has also begun to respond. Florida Senator Rick Scott introduced a bill last month to ban surrogacy by citizens of certain countries, including China, citing human trafficking probes.

Lawmakers pushing restrictions have framed the issue around trafficking concerns, weak oversight and what they describe as loopholes that enable foreign reproductive tourism. Their focus has widened beyond individual disputes to the larger structure that allows foreign clients to arrange births in the United States and secure citizenship for the children.

The cases involving Chinese billionaires have sharpened that focus because of their scale. Xu’s acknowledged total of “only a little over 100” U.S. surrogacy births, combined with Tang’s disputed claim of as many as 300 children across countries, has pushed the issue beyond ordinary family-law arguments and into national politics.

The Los Angeles ruling against Xu showed that courts can resist intended parent claims in unusual cases, but it also exposed how unsettled some questions remain once children are already born. The 4 children at issue were left without the parentage outcome Xu sought, an outcome that underscored the legal strain these arrangements can place on the system.

Critics say the concerns extend beyond citizenship. They point to the risk that surrogates can be treated as part of a production chain, especially when intended parents pursue many births across different women and different jurisdictions.

They also warn about the ethics of “mega-families,” where one intended parent or couple seeks very large numbers of children through repeated surrogacy contracts. In those cases, the concern is not only who pays for the process, but whether legal systems built for ordinary family formation can manage arrangements on an industrial scale.

Supporters of surrogacy rights, fertility businesses and intended parents have long argued that the process can be lawful and carefully managed through contracts, medical screening and court approval. But the cases now under scrutiny have given opponents new material to argue that existing rules do not adequately police abuse.

The current fight over birthright citizenship has made those arguments more politically charged. Because children born on U.S. soil are generally treated as citizens at birth, any case involving wealthy foreign intended parents and multiple American-born children quickly reaches beyond family courts and into immigration politics.

That is one reason Xu Bo, birthright citizenship and the role of Chinese billionaires in the U.S. surrogacy market have become linked in public debate. What began as a niche cross-border fertility practice is now being examined as a question of constitutional law, border policy and the limits of private wealth.

Even so, the practical appeal of the United States has not disappeared. Surrogacy businesses still offer a legal environment that many intended parents view as more predictable than alternatives abroad, especially after restrictions in China pushed demand outward.

That leaves U.S. courts, federal investigators and lawmakers confronting a fast-growing conflict between settled citizenship doctrine and a surrogacy market that can operate across continents. With judges reviewing parentage disputes, federal agencies interviewing surrogates and Congress considering restrictions, the children born through these arrangements remain at the center of a debate the law did not anticipate.